腾盛博药(02137.HK)拟斥最多6,000万元回购股份

阿斯达克财经
Dec 20, 2024

腾盛博药-B(02137.HK) 公布,有意根据股东于今年6月25日通过的决议案,授予董事的一般授权行使其权力,以购回不超过于今年6月25日的已发行股份总数10%的腾盛博药股份。考虑到公司股价现时处于业绩、资产价值及业务前景被低估的水平,董事会于今日(20日)决议动用购回授权,不时因应市况于公开市场积极推行场内股份购回计划。据该股份购回计划,用于购回股份的资金总额不超过6,000万元,股份购回计划...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10